FDA Needs Food Safety Overhaul: Report
Focus must shift from reacting to illness outbreaks to preventing them, experts say
The U.S. Food and Drug Administration (FDA) isn’t equipped to handle problems with the food supply and is in need of a major revamping, a government panel of experts reported Tuesday.
To come up to speed, the FDA needs to squarely focus its efforts on identifying and addressing high-risk areas and on preventing foodborne illness in the first place, stated the report, issued today by the Institute of Medicine (IOM) and the National Research Council at the request of Congress.
Among other things, the report recommends giving the FDA authority to issue mandatory recall of food products and to delegate responsibility for inspections to states, which already handle about 60 percent of this task.
“The agency’s approach now is too reactive and lacks a systematic focus on prevention,” Dr. Robert Wallace, chairman of the committee that prepared the report and professor of epidemiology and internal medicine at the University of Iowa College of Public Health, said at a Tuesday news conference. “The time has come to modernize the FDA’s food safety program focusing on the development of an integrated, risk-based system.”
A leading consumer group applauded the report.
“A distinguished panel of experts has concluded that FDA has neither the resources nor the powers it needs to keep our food safe,” Jean Halloran, director of food policy initiatives at Consumers Union, said in a prepared statement. “The report recommends that Congress act to give FDA the power to order recalls of tainted food, which amazingly, it still lacks. The report further urges that Congress require all food processors to register with the FDA, to act proactively to prevent foodborne illness, and tell the FDA when they discover adulterated products. FDA needs all these powers as well as a mandate to inspect high-risk processors at least annually. While the House passed a bill last July that would give FDA much of what it needs, the reform legislation remains stalled in the Senate. The time is now for Congress to act.”

